מחקר: Skin Crossover (23)
23 מאמרים בנושא Skin Crossover, מאונדקסים על ידי PF-Atlas מ-PubMed וכתבי עת עולמיים.
מחקר בין-מחלתי. מחקרים אלה מתחומים פיברוטיים, אונקולוגיים או רגנרטיביים קשורים ובמעקב לשם רלוונטיות מנגנונית ל-IPF. הם אינם ראיה ישירה לטיפול בפיברוזיס ריאתי אידיופתי.
- Combined All-trans Retinoic Acid and Rosiglitazone Alleviates Scleroderma Fibrosis by Suppressing the STAT3/Th17 Axis. · In vivo (Athens, Greece) · 2026
- Atorvastatin alleviates the progression of fibrosis in experimental systemic sclerosis: Binding to macrophage CD14 to regulate TLR4/p65 or directly modulating fibroblast Smad3 signaling. · Free radical biology & medicine · 2026
- 3D-Mesenchymal stromal cells derived VASH2 alleviates oxidative stress-induced endothelial senescence by mediating α-tubulin detyrosination in systemic sclerosis. · Journal of translational medicine · 2026
- MSCs derived from ADSC-reprogrammed iPSCs exhibit enhanced therapeutic potential for treating skin fibrosis. · Stem cells translational medicine · 2026
- Intralesional Adipose-Derived Stem Cells Reverse Established Dermal Fibrosis and Modulate Angiogenesis-Related Readouts in a Murine Systemic Sclerosis Model. · Tissue engineering and regenerative medicine · 2026
- Network pharmacology and in vivo experimental analysis for validating the antifibrotic potential of Punica granatum leaves against skin scleroderma: the role of oxidative stress, inflammation and TGF-β1/Snail 1/p-Smad 3 signaling pathway. · Inflammopharmacology · 2026
- Pioglitazone in Skin Fibrosis: Mechanistic Rationale and Therapeutic Potential of Pioglitazone for Scarring Dermatoses. · Journal of visualized experiments : JoVE · 2026
- A novel microneedle-based delivery of NRF2-overexpressing exosomes for scleroderma therapy. · International journal of biological macromolecules · 2025
- The senescence-like activity of BMS-470539 is associated with anti-fibrotic actions in models of dermal fibrosis. · Arthritis research & therapy · 2025
- Diagnostics, Efficacy, and Safety of Immunomodulatory and Anti-Fibrotic Treatment for Interstitial Lung Disease Associated with Systemic Scleroderma . · Diagnostics (Basel, Switzerland) · 2025
- Apoptotic Bodies Restore NAD and Mitochondrial Homeostasis in Fibroblasts. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
- Pirfenidone in Skin Fibrosis and Scarring: From Bench Insights to Clinical Data. · Medical sciences (Basel, Switzerland) · 2025
- Systemic sclerosis and AHR: Shedding light on a hidden connections. · Autoimmunity reviews · 2025
- Aberrant Chitinase 3-Like 1 Expression in Basal Cells Contributes to Systemic Sclerosis Fibrosis. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
- Talabostat, fibroblast activation protein inhibitor, attenuates inflammation and fibrosis in systemic sclerosis. · Inflammopharmacology · 2024
- Stem cell-based therapy for fibrotic diseases: mechanisms and pathways. · Stem cell research & therapy · 2024
- Upregulation of GPX4 drives ferroptosis resistance in scleroderma skin fibroblasts. · Free radical biology & medicine · 2024
- Ketotifen directly modifies the fibrotic response of human skin fibroblasts. · Scientific reports · 2024
- Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis. · Molecular aspects of medicine · 2024
- Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis. · Clinical and experimental pharmacology & physiology · 2024
- Lead generation from N-[benzyl carbamoyl]amino acid as a novel LPA antagonist for the treatment of systemic sclerosis. · European journal of medicinal chemistry · 2023
- Back to the future: targeting the extracellular matrix to treat systemic sclerosis. · Nature reviews. Rheumatology · 2023
- A cysteine proteinase inhibitor ALLN alleviates bleomycin-induced skin and lung fibrosis. · Arthritis research & therapy · 2023
הבהרה רפואית. רשימות מחקר הן למידע בלבד ואינן ייעוץ רפואי.